Active Diabetes, Hormones & Metabolism NIHR-supported project Brain & Nervous System
An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verapamil SR therapy on the preservation of beta-cell function.
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Simon Heller (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on preservation of beta-cell function (Ver-A-T1D)
A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on preservation of beta-cell function
A randomised, double-blind, placebo controlled, parallelgroup, multi-centre trial in adult subjects with newlydiagnosed type 1 diabetes mellitus investigating the effect ofVerapamil SR on preservation of beta-cell function (Ver-AT1D)
VER-A-T1D A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on preservation of beta-cell function
Targeting beta-cell function to achieve remission of type 2 diabetes (REACTIVATE). An open-label, single-centre, randomised, parallel study to assess the efficacy, safety and utility of fully closed-loop insulin delivery in achieving remission of diabetes compared to standard therapy with a glucose sensor in adults with recent onset type 2 diabetes
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know